We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Bruker Announces Agreement to Acquire Michrom

Read time: Less than a minute

In particular, Michrom recently has launched the novel Advance™ nanoflow ultra-high performance liquid chromatography (UHPLC) system and proprietary CaptiveSpray™ Ionization (CSI) sources for coupling to mass spectrometry (MS) in proteomics and other life-science applications.

Financial details of the transaction were not disclosed, and the closing is expected within weeks. Michrom's revenue was approximately $3 million in 2010. Bruker intends to retain all of Michrom's employees, and Michrom's founder and president, Mr. Kerry Nugent, is expected to join Bruker as 'Senior Vice President - Liquid Chromatography'.

In commenting on the agreement, Mr. Collin D'Silva, president of Bruker's Chemical & Applied Markets division, said: "Michrom's broad portfolio of novel technologies and high-performance products is highly complementary to our mass spectrometry products. In particular, Michrom's new high duty-cycle nanoflow UHPLC platform, along with their revolutionary CaptiveSpray™ LC-MS interface, together will provide our customers with significant gains in throughput, sensitivity and robustness for proteomics and other nano and capillary flow LC-MS applications."

Michrom's president Kerry Nugent expects the transaction to make Michrom's products more widely available to global customers seeking these key novel technologies.

He commented: "With Bruker's Fremont, California manufacturing infrastructure and well-developed global distribution channels, we will be able to make greater strides to provide customers with advanced analytical solutions that embody technologies based on our expertise in biochemistry and micro-fluidics. I am very excited that the significant potential of our new technologies is now closer to being realized by more discerning customers."